570.705 USD
-3.52 (-0.61%)
ISRG gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ISRG a very profitable company, without any liquidiy or solvency issues. ISRG is growing strongly while it is still valued neutral. This is a good combination! This makes ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
ISRG had a positive operating cash flow in the past year.
In the past 5 years ISRG has always been profitable.
In the past 5 years ISRG always reported a positive cash flow from operatings.
1.2 Ratios
ISRG has a Return On Assets of 14.19%. This is amongst the best in the industry. ISRG outperforms 95.74% of its industry peers.
The Return On Equity of ISRG (16.12%) is better than 90.96% of its industry peers.
ISRG's Return On Invested Capital of 14.96% is amongst the best of the industry. ISRG outperforms 95.21% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ISRG is above the industry average of 8.71%.
The last Return On Invested Capital (14.96%) for ISRG is above the 3 year average (12.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
The Profit Margin of ISRG (28.58%) is better than 96.28% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 29.44%, ISRG belongs to the best of the industry, outperforming 97.34% of the companies in the same industry.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG has a Gross Margin of 66.38%. This is in the better half of the industry: ISRG outperforms 69.15% of its industry peers.
ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ISRG has more shares outstanding
Compared to 5 years ago, ISRG has more shares outstanding
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.73
WACC8.64%
2.3 Liquidity
A Current Ratio of 4.97 indicates that ISRG has no problem at all paying its short term obligations.
The Current ratio of ISRG (4.97) is better than 78.19% of its industry peers.
A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
ISRG's Quick ratio of 4.20 is fine compared to the rest of the industry. ISRG outperforms 78.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.12%, which is quite impressive.
ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
Looking at the last year, ISRG shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.47% yearly.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ISRG is valuated quite expensively with a Price/Earnings ratio of 66.28.
Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than 67.02% of the companies in the same industry.
ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.15.
Based on the Price/Forward Earnings ratio of 57.69, the valuation of ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.28 | ||
| Fwd PE | 57.69 |
4.2 Price Multiples
66.49% of the companies in the same industry are more expensive than ISRG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 69.68% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 90.07 | ||
| EV/EBITDA | 57.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as ISRG's earnings are expected to grow with 15.85% in the coming years.
PEG (NY)3.33
PEG (5Y)5.77
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ISRG (11/28/2025, 10:44:06 AM)
570.705
-3.52 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change3.04%
Ins Owners0.45%
Ins Owner Change0.58%
Market Cap204.59B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target610.08 (6.9%)
Short Float %1.92%
Short Ratio2.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)2.11%
PT rev (3m)1.86%
EPS NQ rev (1m)3.24%
EPS NQ rev (3m)3.25%
EPS NY rev (1m)5.67%
EPS NY rev (3m)5.61%
Revenue NQ rev (1m)1.69%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)1.24%
Revenue NY rev (3m)1.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.28 | ||
| Fwd PE | 57.69 | ||
| P/S | 21.28 | ||
| P/FCF | 90.07 | ||
| P/OCF | 69.1 | ||
| P/B | 12 | ||
| P/tB | 12.26 | ||
| EV/EBITDA | 57.24 |
EPS(TTM)8.61
EY1.51%
EPS(NY)9.89
Fwd EY1.73%
FCF(TTM)6.34
FCFY1.11%
OCF(TTM)8.26
OCFY1.45%
SpS26.81
BVpS47.54
TBVpS46.57
PEG (NY)3.33
PEG (5Y)5.77
Graham Number95.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.64%
ROIC/WACC1.73
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.